ADUS

Addus HomeCare Corp
7 filings tracked
healthcarehome healthcare servicesMID ($2B-10B)

Company Intelligence Hub

Filing history, signal momentum, and bull/bear evolution

Chronological Filing Evolution (Click to filter / toggle)

Thesis (Bull Case Evolution)

Addus HomeCare is demonstrating a potent combination of organic growth and disciplined capital allocation. The company reported a 7.7% year-over-year increase in net service revenues to $363.6 million for the first quarter of 2026, with net income surging 18.1% to $25.1 million.…

Bullish Outlook

Antithesis (Bear Case / Structural Risks)

Despite the headline growth, a closer look at the financials reveals significant vulnerabilities.…

Risk Factors

Read the full bull/bear analysis

You are reading the free preview. Start a free trial to unlock the complete bull & bear analysis for every ADUS filing.

Start Free Trial

Synthesis (Verdict & Resolution)

The Q1 2026 filing presents a company in transition, balancing impressive cash flow generation against systemic regulatory risks. On one hand, the operational metrics—specifically the compression of days sales outstanding to 36 days and the surge in net income—point to a highly efficient management team. The successful divestiture of New York operations and the acquisition of HomeCourt Home Care in Indiana show a disciplined approach to geographic optimization. However, the overarching narrative is one of dependency. Addus is tethered to the budgetary whims of the Illinois government and the federal CMS payment schedules. While the shift toward managed care offers a path toward diversification, the short-term outlook remains sensitive to variable interest rates and potential Medicaid contractions. Investors are essentially weighing the company's exceptional current cash conversion against the binary risk of state-level reimbursement shifts.

Selected Quarter

Core Takeaway

Addus is converting revenue to cash at an accelerating rate, but its geographic concentration in Illinois creates a single point of failure for the investment thesis.

Investor Lens

The trade-off is between the company's current operational excellence and its lack of payor diversification.

Watch Next

FY 2026 reimbursement rate updates from the Illinois Department on Aging and the impact of the OBBBA on federal matching funds.

Signal Momentum Chart

Quarterly net bull/bear signal ratio. Click nodes to select a quarter.

BULLISH (+1.0)NEUTRAL (0.0)BEARISH (-1.0)+0.28Q2 '26 (10-Q)

Signal Timeline

Active Filters:Quarter: Q2 '26 (10-Q)
bullishMay 5

Net income grew 18.1% year-over-year to $25.1 million.

earnings beat
80%
bullishMay 5

Operating margins expanded to 9.4% from 9.0%.

margin expansion
40%
bullishMay 5

Repaid $30 million of revolving credit facility debt.

debt restructure
60%
bearishMay 5

Potential Medicaid spending reductions under the OBBBA legislation.

regulatory action
70%
bullishMay 5

Net income grew 18.1% year-over-year to $25.1 million.

earnings beat
80%
bullishMay 5

Operating margins expanded to 9.4% from 9.0%.

margin expansion
40%
bullishMay 5

Repaid $30 million of revolving credit facility debt.

debt restructure
60%
bearishMay 5

Potential Medicaid spending reductions under the OBBBA legislation.

regulatory action
70%
bullishMay 5

Net income grew 18.1% year-over-year to $25.1 million.

earnings beat
80%
bullishMay 5

Operating margins expanded to 9.4% from 9.0%.

margin expansion
40%
bullishMay 5

Repaid $30 million of revolving credit facility debt.

debt restructure
60%
bearishMay 5

Potential Medicaid spending reductions under the OBBBA legislation.

regulatory action
70%
bullishMay 5

Net income grew 18.1% year-over-year to $25.1 million.

earnings beat
80%
bullishMay 5

Operating margins expanded to 9.4% from 9.0%.

margin expansion
40%
bullishMay 5

Repaid $30 million of revolving credit facility debt.

debt restructure
60%
bearishMay 5

Potential Medicaid spending reductions under the OBBBA legislation.

regulatory action
70%
bullishMay 5

Net income grew 18.1% year-over-year to $25.1 million.

earnings beat
80%
bullishMay 5

Operating margins expanded to 9.4% from 9.0%.

margin expansion
40%
bullishMay 5

Repaid $30 million of revolving credit facility debt.

debt restructure
60%
bearishMay 5

Potential Medicaid spending reductions under the OBBBA legislation.

regulatory action
70%
bullishMay 5

Net income grew 18.1% year-over-year to $25.1 million.

earnings beat
80%
bullishMay 5

Operating margins expanded to 9.4% from 9.0%.

margin expansion
40%
bullishMay 5

Repaid $30 million of revolving credit facility debt.

debt restructure
60%
bearishMay 5

Potential Medicaid spending reductions under the OBBBA legislation.

regulatory action
70%
bullishMay 5

Net income grew 18.1% year-over-year to $25.1 million.

earnings beat
80%
bullishMay 5

Operating margins expanded to 9.4% from 9.0%.

margin expansion
40%
bullishMay 5

Repaid $30 million of revolving credit facility debt.

debt restructure
60%
bearishMay 5

Potential Medicaid spending reductions under the OBBBA legislation.

regulatory action
70%

Filing History

10-QMay 5, 2026
Expand Sequence

The Q1 2026 filing presents a company in transition, balancing impressive cash flow generation against systemic regulatory risks. On one hand, the operational metrics—specifically the compression of days sales outstanding to 36 days and the surge in net income—point to a highly efficient management team. The successful divestiture of New York operations and the acquisition of HomeCourt Home Care in Indiana show a disciplined approach to geographic optimization. However, the overarching narrative is one of dependency. Addus is tethered to the budgetary whims of the Illinois government and the federal CMS payment schedules. While the shift toward managed care offers a path toward diversification, the short-term outlook remains sensitive to variable interest rates and potential Medicaid contractions. Investors are essentially weighing the company's exceptional current cash conversion against the binary risk of state-level reimbursement shifts.

Disclaimer: The synthesis provided is generated by AI models and should not be construed as investment advice. Analysis is based solely on regulatory data present at the time of publication. Consult a financial advisor for specific investment strategies.